Prompt recognition of an immune-mediated transfusion reaction is fundamental to improving patient outcome.
Immune-mediated transfusion reactions can be classified as acute or delayed. Acute reactions occur within 24 hours of transfusion and include acute hemolytic, febrile nonhemolytic, allergic, and transfusion-related acute lung injury (TRALI). Delayed reactions occur days to weeks after the transfusion and include delayed hemolytic transfusion reactions, transfusion-associated graft-versus-host disease, and post-transfusion purpura.
Prompt recognition of an immune-mediated transfusion reaction is fundamental to improving patient outcome. Although infrequent, nonimmune transfusion reactions, including hemolysis, transfusion-associated sepsis, and circulatory overload, should be considered in the differential diagnosis.
Acute hemolytic transfusion reactions are most often the result of clerical error. Identification is critical because of the high probability of a second patient receiving the wrong blood product at the same time.
Treatment depends upon the type of transfusion reaction. Although pretransfusion prophylactic acetaminophen and diphenhydramine are often routinely administered, there is little evidence to support this practice.
This topic will mainly address immune-mediated transfusion reactions, which comprise an array of distinct adverse clinical responses to transfusion. They are mediated by the interaction of recipient antibodies to foreign antigens contained in any allogeneic blood products. Acute immune-mediated transfusion reactions occur immediately following, or within 24 hours of, a transfusion. They include acute hemolytic, febrile nonhemolytic, allergic (with or without anaphylaxis), and transfusion-related acute lung injury (TRALI). Delayed immune-mediated transfusion reactions occur within days to weeks of transfusion and include delayed hemolytic transfusion reaction, graft-versus-host disease, and post-transfusion purpura.
Associate Professor of Surgery
Creighton University School of Medicine
St. Joseph’s Hospital and Medical Center
JAW declares that he has no competing interests.
Associate Professor of Medicine
Innsbruck Medical University
CP declares that he has no competing interests.
Professor of Pathology
University of Alabama at Birmingham Hospital
MM declares that she has no competing interests.
Use of this content is subject to our disclaimer